NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

ChtrB.01238.a: Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)

Target Characteristics

from organism: Chlamydia trachomatis D/UW-3/Cx
most recent status: cloned
center reference id: ChtrB.01238.a
is community request: True
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
non-BEI

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Molecular models

Method Results
comparative modelling Robetta_82018

External Resources

Resource Reference ID
PATRIC ID: fig|272561.5.peg.802
UniProt: O84734

Enzyme & Pathway Information

Pathway Pathway ID EC Number
L-selenocysteine biosynthesis I (bacteria) PWY0-901 6.1.1.11
L-selenocysteine biosynthesis II (archaea and eukaryotes) PWY-6281 6.1.1.11
tRNA charging TRNA-CHARGING-PWY 6.1.1.11

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MLDIRLIRKE PKECESRLQK KDPAISLERL LDLDKTVRQL KADSEALLAK RKVLSGQIHK AKVANENADA LIQEVNTIAD QLVAFETTLQ EQEALLEDLM ARLPNYPDED VPVSPDKTGN QVIKGHGEVP TFPFPPKHHM QLNEALQILD FKLPAKTTGS GWPAYCNEGV LLEWALLTYL LNKQQAHGFQ LWLPPLLVKR DILFGSGQIP KFDGQYYRVE DGDQSLFLIP TAEVVLNGFH SQEILNEQDL PLCYAAFTPC FRREAGAGGA HERGLVRVHQ FHKVEMFAFT TPEQEEVVYQ KMLHVVEEIL SELQLPYQLS LLSTGDMSFT AKKTIDAEVW LPGQKAFYEV SSISKCGDFQ ARRSETRYRD AQGKLHFVNT LNGSGLATPR LLVAILENYQ QADGSVVIPS VLRPYMNNQE ILLPKTVR

NT Sequence
atgttagata tacgattaat acgcaaggaa ccaaaagagt gcgaaagccg tcttcaaaaa aaagatcccg ctatttcttt agaacgcctc ctagacttgg ataaaactgt gcgtcagtta aaggcggatt cagaagctct gcttgcaaag cgtaaggtat tatctggtca gattcataaa gctaaagttg ctaacgaaaa tgctgacgcc ttgattcaag aagtgaatac tattgcagat caactcgttg catttgaaac aactttgcaa gaacaggaag cacttctaga agatctcatg gcgagactgc ctaattatcc agatgaagat gttccagttt ctcctgataa aacaggaaac caagtgatta aaggccacgg tgaggtacct acttttcctt tccctcccaa acaccatatg caacttaatg aagcgttgca aattttagac tttaaactcc ctgccaaaac tacagggtct ggctggccgg cttattgtaa tgaaggagtt cttctagaat gggctctgct tacttatctt ctgaataaac agcaagcaca tggctttcaa ttgtggctcc ctcccttact tgttaaacga gatattctct tcggttcagg acaaattcct aagttcgatg gacagtatta ccgtgttgag gatggagatc agtctctttt ccttatcccg acagcagaag tcgtcctcaa tggattccat tctcaagaaa ttctaaatga gcaagatctc cctctctgtt atgctgcatt tactccctgc ttccgcagag aggctggcgc tggaggagct cacgaacgag gacttgtgcg agtccatcag ttccacaaag tagaaatgtt tgctttcact actccggaac aagaagaagt tgtctatcaa aaaatgcttc atgttgtgga agaaattctg tctgaactgc aactccccta tcagctttcc ttactttcca caggagacat gtcattcact gctaagaaaa cgatcgatgc agaagtgtgg ctcccaggac aaaaagcgtt ctatgaagtc tcctctattt ctaaatgcgg agattttcaa gctcgacgat ccgaaacacg ctatcgagat gctcaaggta aattgcactt cgttaacact ctaaacggct ctggattggc aacgccaaga ttgttggtcg ctattttaga aaattatcag caagcggatg gctctgtcgt cattccttct gttcttcgcc cctatatgaa taaccaagag attctcctac ccaaaacggt aagataa

© 2020 Seattle Children's Research Institute. All rights reserved.